Amarnath Challapalli, MBBS, MD, MRCP, FRCR, PhD, discusses some of the most promising findings from the EPIC-A trial of cemiplimab with chemotherapy in treating locally advanced or metastatic penile carcinoma.
Amarnath Challapalli, MBBS, MD, MRCP, FRCR, PhD
Advertisement
Amarnath Challapalli, MBBS, MD, MRCP, FRCR, PhD, is a consultant clinical oncologist at Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust.
Articles by Amarnath Challapalli, MBBS, MD, MRCP, FRCR, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
